- Home
- WNC vs MDXG Comparison
WNC vs MDXG Comparison
Compare WNC & MDXG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | WNC | MDXG |
|---|---|---|
| Founded | 1985 | 2006 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Construction/Ag Equipment/Trucks | Biotechnology: Pharmaceutical Preparations |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 571.9M | 672.8M |
| IPO Year | 2009 | 2007 |
Fundamental Metrics
Financial Performance| Metric | WNC | MDXG |
|---|---|---|
| Price | $12.38 | $4.35 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 2 | 5 |
| Target Price | ★ $22.50 | $7.40 |
| AVG Volume (30 Days) | 772.6K | ★ 1.0M |
| Earning Date | 10-29-2026 | 10-28-2026 |
| Dividend Yield | ★ 2.59% | N/A |
| EPS Growth | ★ 179.22 | 14.29 |
| EPS | N/A | ★ N/A |
| Revenue | ★ $2,027,489,000.00 | $418,630,000.00 |
| Revenue This Year | $2.31 | N/A |
| Revenue Next Year | $29.64 | $21.14 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | 8.81 | ★ 19.99 |
| 52 Week Low | $6.63 | $3.03 |
| 52 Week High | $14.55 | $7.97 |
Technical Indicators
Market Signals| Indicator | WNC | MDXG |
|---|---|---|
| Relative Strength Index (RSI) | 43.53 | 37.24 |
| Support Level | $11.58 | $4.11 |
| Resistance Level | $13.02 | $4.48 |
| Average True Range (ATR) | 0.57 | 0.16 |
| MACD | -0.10 | -0.03 |
| Stochastic Oscillator | 15.54 | 20.33 |
Price Performance
Historical ComparisonAbout WNC Wabash National Corporation
Wabash National Corp operates as the innovation leader of connected solutions for the transportation, logistics, and distribution industries. The Company manages its business in two operating and reportable segments: Transportation Solutions and Parts & Services. It designs and manufactures products including dry freight and refrigerated trailers, platform trailers, tank trailers, dry and refrigerated truck bodies, structural composite panels and products, trailer aerodynamic solutions, and specialty food-grade processing equipment.
About MDXG MiMedx Group Inc
MiMedx Group Inc develops and markets regenerative biomaterial products and bioimplants made from the human amniotic membrane, birth tissues, and human skin & bone. Its products are targeted towards the wound-care, burn, surgical, sports medicine, and orthopedics markets. MiMedx's key products are allografts processed from amniotic tissue, which include EpiFix for external use and AmnioFix for internal use. AmnioCord, AmnioFill, EpiBurn, and EpiCord are some of its other products. Also, the company sells allografts for ophthalmic surgery and dental applications through licenses to third parties.